HUBERT E MD HUCKEL
CIK 1121608 · last filed 2014-10-06
HUBERT E MD HUCKEL is a corporate insider who has filed 30 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for CPRX, was dated Oct 6, 2014. Across all open-market trades the lifetime net is +$300.7K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $84.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$84.00M
4
30
$300.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CPRX | Director | 2,638,268 | $31.49 | $83.08M | $225.7K | 14 | 2014-10-06 |
| KOOL | Director | 65,000 | $14.19 | $922.1K | $284.0K | 10 | 2011-07-01 |
| TITAN PHARMACEUTICALS INC (TTP) Delisted | Director | — | $47.61 | — | $0 | 2 | 2008-06-03 |
| Valera Pharmaceuticals Inc (VLRX) Delisted | Director | 0 | — | — | -$209.0K | 2 | 2007-04-18 |
Recent Filings
30 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-10-06 | CPRX | Mixed | +20,036 | $27.0K | EDGAR |
| 2014-09-02 | CPRX | Grant (A) | — | $0 | EDGAR |
| 2012-12-14 | CPRX | Grant (A) | — | $0 | EDGAR |
| 2012-05-29 | CPRX | Buy (P) | +125,000 | $100.0K | EDGAR |
| 2012-01-05 | — | Grant (A) | — | $0 | |
| 2011-12-19 | CPRX | Grant (A) | — | $0 | EDGAR |
| 2011-07-01 | KOOL | Grant (A) | — | $0 | EDGAR |
| 2011-04-19 | — | Grant (A) | — | $0 | |
| 2010-11-10 | CPRX | Grant (A) | — | $0 | EDGAR |
| 2010-11-02 | KOOL | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.